Search the Newsreel

Arrowhead Pharmaceuticals (ARWR) Could Be 3% Undervalued On Late Stage Trial Progress

Arrowhead Pharmaceuticals (ARWR) appears to be 3% undervalued, according to a recent analysis, following positive late-stage trial data for two RNA interference programs. The company's stock has seen significant momentum, with a 7x return over the past year, driven by reassessments of its risk …

Do Harrow’s (HROW) Retina Data Updates Quietly Redefine Its Core Growth Strategy?

Renaissance Technologies LLC Boosts Stock Position in Arrow Electronics, Inc. $ARW

Renaissance Technologies LLC increased its stake in Arrow Electronics (NYSE:ARW) by 3.6% in the first quarter, bringing its total holdings to 168,957 shares valued at $24.2 million. This comes as Arrow Electronics reported strong quarterly earnings, beating analyst expectations with $5.22 EPS and $9.47 …

The Bull Case For Arrowhead Pharmaceuticals (ARWR) Could Change Following Dual Phase 3 RNAi Cardiometabolic Milestones

Arrowhead Pharmaceuticals recently reported that its siRNA drug plozasiran met all primary and key secondary endpoints in two global Phase 3 trials for severe hypertriglyceridemia, while also completing patient enrollment for the YOSEMITE Phase 3 trial of zodasiran in the ultra-rare condition homozygous familial …

AROW|Arrow Financial Corp|Price:39.825|Chg%:-0.115

TradingKey provides a comprehensive stock analysis of Arrow Financial Corp (AROW), highlighting its stable fundamentals, high growth potential, and fair valuation. The company shows strong financials with high revenue and profit growth, consistent dividends, and significant institutional ownership. Despite its strengths, the stock is …

Arrow Electronics Inc (ARW) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Arrow Electronics Inc (ARW), detailing its price momentum score of 3.58 and noting that the stock is trading between a resistance level of 220.65 and a support level of 189.55, suggesting it's suitable for range-bound swing trading. …

Arrow Electronics Number of Employees 2026 | Employee Count & Headcount Data

Arrow Electronics, Inc. had approximately 22,507 employees worldwide as of March 2026, representing a 4.2% growth since 2023. The company is actively hiring, with 1,877 job postings in 2026, a 19.3% increase from 2025. The workforce is concentrated in North America, South Asia, and …

Harrow Inc (HROW) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis of Harrow Inc (HROW), noting its current valuation score of 9.51, which ranks 17th out of 155 companies in the Pharmaceuticals industry. It highlights the company's P/E ratio is -101.17, significantly below its recent high and above its …

Bank of Nova Scotia Boosts Holdings in Arrow Electronics, Inc. $ARW

Bank of Nova Scotia significantly increased its stake in Arrow Electronics, Inc. (NYSE:ARW) by 112.2% in the first quarter, now owning 25,257 shares valued at $3.62 million. Other institutional investors like Sei Investments Co. and Walleye Capital LLC also adjusted their positions. The company …

Equities Analysts Set Expectations for ARWR FY2027 Earnings

Arrow Financial Corporation Revenue Breakdown – NASDAQ:AROW

Arrow Electronics Inks A Deal With Thai IoT and Embedded Systems Associations

Arrow Electronics has partnered with the Thai IoT Association (TIoTA) and the Thai Embedded Systems Association (TESA) to foster technology innovation and strengthen Thailand's electronics industry. This collaboration aims to promote advanced technologies like AI, IoT, and embedded systems through various initiatives. These efforts …

Arrowhead Pharmaceuticals Number of Employees 2026 | Employee Count & Headcount Data

Arrowhead Pharmaceuticals (ARWR) had 801 employees worldwide as of March 2026, marking a 51.4% growth since 2023. The company is actively hiring, with 152 active job postings in 2026, and its workforce is primarily concentrated in the United States. Revelio Labs data indicates that …

Arrowhead Pharmaceuticals, Inc. Stock 12‑Month Price Target Raised to $105.4, Implies 23% Upside

Arrowhead Pharmaceuticals, Inc.'s stock 12-month price target has been increased from $104.7 to $105.4 by analysts, indicating a potential 23% upside from its July 27th closing price. The consensus rating from 14 analysts remains a "Buy," with a range of forecasts from $87 to …

The Technical Signals Behind (BANX) That Institutions Follow

This article analyzes the technical signals for Arrowmark Financial Corp. (NASDAQ: BANX), indicating a neutral sentiment with a mid-channel oscillation pattern. AI models suggest three trading strategies—Position, Momentum Breakout, and Risk Hedging—along with multi-timeframe signal analysis, identifying support and resistance levels. The report highlights …

AROW Reiterated by Piper Sandler -- Price Target Raised to $46.0

Piper Sandler has reiterated its Overweight rating for Arrow Financial (AROW), raising the price target from $43.00 to $46.00, reflecting confidence in the company's growth potential within the financial services sector. Despite this positive analyst outlook, GuruFocus indicates that AROW is currently 11.0% overvalued …

AVT vs. ARW: Which AI Supply Chain Stock Is the Better Buy?

Avnet, Inc. AVT and Arrow Electronics, Inc. ARW are two crucial players in the global electronic components distribution industry, serving as key supply chain partners for semiconductor manufacturers and technology companies. Both companies are benefiting from accelerating investments in artificial intelligence (AI), cloud computing, …

Arrow Electronics (NYSE:ARW): High Growth Momentum Meets Breakout Setup

Arrow Electronics (NYSE:ARW) has been identified as a stock with strong growth momentum and a favorable technical setup, combining a high technical rating, setup rating, and High Growth Momentum (HGM) rating. The company exhibits robust financial performance with significant EPS and sales growth, consistent …

First Trust Advisors LP Has $37.28 Million Stake in Arrow Electronics, Inc. $ARW

First Trust Advisors LP increased its stake in Arrow Electronics, Inc. (NYSE:ARW) by 27.8% during the first quarter, bringing its total holdings to 259,982 shares valued at $37.28 million. Other institutional investors have also adjusted their positions, while insiders have recently sold shares. Analyst …

Arrow Minerals Issues 42.4 Million Shares as Niagara Project Milestone Payment

Arrow Minerals Lists 3.29 Million Shares as Final Payment for Niagara Project Acquisition

Arrow Minerals Issues 3.3 Million Shares as Payment for Niagara Project Tranche One Option Fee

Arrowhead Pharmaceuticals (ARWR) Expected to Announce Earnings on Tuesday

Arrowhead Pharmaceuticals Completes Enrollment in Global Phase 3 YOSEMITE Study of Zodasiran for the Treatment of Homozygous Familial Hypercholesterolemia

Arrowhead Pharmaceuticals has completed enrollment in its global Phase 3 YOSEMITE clinical trial for zodasiran, an investigational RNAi therapeutic targeting homozygous familial hypercholesterolemia (HoFH). The study, which enrolled 70 patients, is expected to be completed in mid-2027, after which Arrowhead plans to seek regulatory …

Arrow Electronics Signs MoUs to Help Advance Technology Innovation in Thailand’s Electronics Industry

Arrow Electronics has signed Memoranda of Understanding (MoUs) with the Thai IoT Association (TIoTA) and the Thai Embedded Systems Association (TESA) to spearhead technology innovation in Thailand's electronics industry. These collaborations aim to advance the adoption of AI, IoT, and embedded systems through joint …

Harrow To Report Second Quarter 2026 Financial Results After Market Close on August 10, 2026

Harrow will report its second-quarter 2026 financial results after the market closes on Monday, August 10, 2026. The company will also host a conference call and live webcast on Tuesday, August 11, 2026, at 8:00 a.m. Eastern Time to discuss the results and provide …

Arrow Financial Corp (AROW) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides a historical timeline of dividend payouts for Arrow Financial Corp (AROW), detailing interim and final cash dividends with their respective record, payment, and ex-dividend dates from 2024 to 2026. It notes that a total of $70.01 million USD has been distributed …

Harrow Inc (HROW) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Harrow Inc (HROW), identifying its major shareholders and institutional holdings. It provides a breakdown of shareholder types, institutional shareholding trends over recent quarters, and recent shareholder activity with changes in holdings for key investors. The article also …

ArrowMark Financial Corp. Revenue Breakdown – GETTEX:S9O

This article provides a revenue breakdown for ArrowMark Financial Corp. (GETTEX:S9O), highlighting that the United States is its primary revenue source. Financial data shows that the U.S. contributed EUR 14.63 million last year, down from EUR 29.09 million the prior year. The information is …

Arrowhead Pharmaceuticals (ARWR) Completes Enrollment in YOSEMITE Trial

Arrowhead Pharmaceuticals announced the completion of enrollment for its Phase 3 YOSEMITE clinical trial for zodasiran, an investigational RNA interference treatment for homozygous familial hypercholesterolemia (HoFH). While this is a significant milestone, the company's financial metrics reflect challenges in profitability and growth, with a …

Arrowhead's Rare Cholesterol Disease Study Reaches 70 Patients

Arrowhead Pharmaceuticals announced the completion of enrollment for its global Phase 3 YOSEMITE clinical trial of zodasiran, an investigational RNA interference therapeutic for homozygous familial hypercholesterolemia (HoFH). The study, which initially aimed for 60 participants but enrolled 70 due to strong interest, is expected …

Harrow Schedules Aug. 11 Call to Discuss Second-Quarter Results

Harrow (Nasdaq: HROW) will report its second-quarter 2026 financial results after the market close on Monday, August 10, 2026. The company will also host a conference call and live webcast to discuss the results and provide a business update at 8:00 a.m. Eastern Time …

5 Stocks That Created Fortunes: CMPS +327%, ARWR +222%, CGON +148%, DRTS +182%, ELMD +86%

(RTTNews) - "If you aren't willing to own a stock for 10 years, don't even think about owning it for 10 minutes." - Warren Buffett. The Oracle of Omaha's timeless advice reminds us that patience is one of the key principles of investing. The …

1,036,495 Shares in Arrowhead Pharmaceuticals, Inc. $ARWR Bought by Renaissance Technologies LLC

Harrow Inc (HROW) Dividends & Stock Splits: Historical Payouts and Event Timeline

The article provides a dividend and stock split history for Harrow Inc (HROW), indicating that the company has not distributed any dividends over the past five years. It also presents current stock performance data, including a market capitalization of $1.43 billion.

Harrow, Inc. Revenue Breakdown – NASDAQ:HROW

Harrow, Inc. (NASDAQ: HROW) generated $272.30 million in revenue last year. Its top-performing segment, Branded, contributed $195.76 million, an increase from $116.11 million the previous year. All of the company's revenue came from the United States market.